Vitelliform Macular Dystrophy Medication Savings with TheDrugClub
Members can check active-formulary eligibility and membership pricing for Vitelliform Macular Dystrophy medications. A condition association alone does not establish coverage.
What Is Vitelliform Macular Dystrophy?
Vitelliform Macular Dystrophy is a medical condition that may require prescription treatment. Consult a healthcare professional about appropriate options.
Managing Vitelliform Macular Dystrophy with TheDrugClub
Eligible medications linked to the active formulary may have no additional cost under listed supply, quantity, fill, and fulfillment limits. Other prescriptions may qualify for membership pricing. Confirm current terms before filling.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
Participating pharmacy savings paths
Directory filing for Vitelliform Macular Dystrophy
In our directory, Vitelliform Macular Dystrophy is filed under Ophthalmology Extended.
Other pages filed under Ophthalmology Extended that share a word in the page name are listed here. Filing them together does not mean they are the same condition.
About Vitelliform macular dystrophy (from MedlinePlus Genetics)
Vitelliform macular dystrophy is a genetic eye disorder that can cause worsening (progressive) vision loss. This disorder affects the retina, the specialized light-sensitive tissue that lines the back of the eye. Specifically, vitelliform macular dystrophy disrupts cells in a small area near the center of the retina called the macula. The macula is responsible for sharp central vision, which is needed for detailed tasks such as reading, driving, and recognizing faces.
Vitelliform macular dystrophy causes a fatty yellow pigment (called lipofuscin) to build up in cells underlying the macula. Over time, large amounts of this substance can damage cells that are critical for clear central vision. As a result, people with this disorder often lose their central vision, and their eyesight may become blurry or distorted. Vitelliform macular dystrophy typically does not affect side (peripheral) vision or the ability to see at night.
Researchers have described two forms of vitelliform macular dystrophy with similar features. The early-onset form (known as Best disease) usually appears in childhood; the age at which symptoms begin and the severity of vision loss vary widely. The adult-onset form begins later, usually in mid-adulthood, and tends to cause vision loss that worsens slowly over time. The two forms of vitelliform macular dystrophy each have characteristic changes in the macula that can be detected during an eye examination.
Source: MedlinePlus Genetics, U.S. National Library of Medicine
This information is educational and is not medical advice.